Fabricante de proveedor intermedio de API de semaglutida (grado farmacéutico)

Semaglutide API Intermediate is a medication for the treatment of type 2 diabetes. Side effects include medullary thyroid cancer, kidney problems, diabetic retinopathy, allergic reactions, low blood sugar, and pancreatitis

Formulario de consulta

    Categoría: Etiquetas: , , ,

    Descripción

    CAS 910463-68-2

    production method: genetic engineering, expressed by E.Coli

    Molecular Formula:c187h291n45o59

    Molecular Weight:4113.58

    Secuencia

    Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH

    Tipo: API

    Grade Standard: Pharma Grade

    Nombre de la marca: zabcbio

    Model Number: ABC206

    contenido de agua≤5%

    Contenido de TFA≤1%

    Pureza ≥ 98%;
    individual impurity≤1%

    ensayo (como es la base) ≥90%;
    Temperatura de almacenamiento 2-8 ℃;
    Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers’ requirement.
    COA: disponible

    Semaglutide host and Semaglutide side chain are available

    On sale: products or technology transfer fee

    Semaglutide API is a medication for the treatment of type 2 diabetes. Side effects include medullary thyroid cancer, kidney problems, diabetic retinopathy, allergic reactions, low blood sugar, and pancreatitis

    Function: Semaglutide is for the treatment of diabetes type 2.

    Para uso exclusivo en investigación. No vendemos a pacientes.

    Advantages

    At present, our main expression system is fusion and tandem copy method expression, polypeptides with other special functions enzyme expressed syncretic by repeated tandem expression, so that the product has a high expression level and avoids the toxicity caused by chemical synthesis.

    Our unique and independent expression system established by our R&D team has been successful tested under the condition of 150L scale, it proves a high-density fermentation process can be industrially Large-scale applicated. The protease produced by self-expression can obtain more than 95% enzyme digestion efficiency, propeptide treatment, intermediate peptide purification, fat chain modification, fine purification, and raw material preparation process.

    La pureza del polvo seco de la materia prima no es inferior a 99%. El tiempo de retención de HPLC y el peso molecular de la espectrometría de masas del fármaco desarrollado por nosotros son completamente consistentes con Novo Nordisk Victoza.

    Third-party lab-tested The cell viability in vitro and PK & PD determination in monkeys, the pharmacokinetics, EC50, and glucagon control effect are consistent with the Novo Nordisk Rybelsus.

    according to 18mg: 3.0ml injection, one kilogram of raw materials can produce 50,000 tablets.

     

    Comentarios

    No hay comentarios aún.

    Sé el primero en opinar "Semaglutide API Intermediate Supplier Manufacturer (Pharma Grade)"

    Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

    es_ESEspañol